Robust identification of significant interactions between toxicogenomic biomarkers and their regulatory chemical compounds using logistic moving range chart
- PMID: 30606695
- DOI: 10.1016/j.compbiolchem.2018.12.020
Robust identification of significant interactions between toxicogenomic biomarkers and their regulatory chemical compounds using logistic moving range chart
Abstract
Identification of significant interactions between genes and chemical compounds/drugs is an important issue in toxicogenomic studies as well as in drug discovery and development. There are some online and offline computational tools for toxicogenomic data analysis to identify the biomarker genes and their regulatory chemical compounds/drugs. However, none of the researchers has considered yet the identification of significant interactions between genes and compounds. Therefore, in this paper, we have discussed two approaches namely moving range chart (MRC) and logistic moving range chart (LMRC) for the identification of significant up-regulatory (UpR) and down-regulatory (DnR) gene-compound interactions as well as toxicogenomic biomarkers and their regulatory chemical compounds/drugs. We have investigated the performance of both MRC and LMRC approaches using simulated datasets. Simulation results show that both approaches perform almost equally in absence of outliers. However, in presence of outliers, the LMRC shows much better performance than the MRC. In case of real life toxicogenomic data analysis, the proposed LMRC approach detected some important down-regulated biomarker genes those were not detected by other approaches. Therefore, in this paper, our proposal is to use LMRC for robust identification of significant interactions between genes and chemical compounds/drugs.
Keywords: Fold change gene expression; Gene-compound interaction; Logistic transformation; Moving range chart; Toxicogenomic data.
Copyright © 2018 Elsevier Ltd. All rights reserved.
Similar articles
-
Robust hierarchical co-clustering for exploring toxicogenomic biomarkers and their chemical regulators.Sci Rep. 2025 May 14;15(1):16676. doi: 10.1038/s41598-025-99568-7. Sci Rep. 2025. PMID: 40369321 Free PMC article.
-
Robust Co-clustering to Discover Toxicogenomic Biomarkers and Their Regulatory Doses of Chemical Compounds Using Logistic Probabilistic Hidden Variable Model.Front Genet. 2018 Nov 1;9:516. doi: 10.3389/fgene.2018.00516. eCollection 2018. Front Genet. 2018. PMID: 30450112 Free PMC article.
-
Identification of potential genomic biomarkers of hepatotoxicity caused by reactive metabolites of N-methylformamide: Application of stable isotope labeled compounds in toxicogenomic studies.Chem Res Toxicol. 2006 Oct;19(10):1270-83. doi: 10.1021/tx060093j. Chem Res Toxicol. 2006. PMID: 17040096
-
Utilizing toxicogenomic data to understand chemical mechanism of action in risk assessment.Toxicol Appl Pharmacol. 2013 Sep 15;271(3):299-308. doi: 10.1016/j.taap.2011.01.017. Epub 2011 Feb 2. Toxicol Appl Pharmacol. 2013. PMID: 21295051 Review.
-
Application of toxicogenomics in hepatic systems toxicology for risk assessment: acetaminophen as a case study.Toxicol Appl Pharmacol. 2011 Jan 15;250(2):96-107. doi: 10.1016/j.taap.2010.10.013. Epub 2010 Oct 21. Toxicol Appl Pharmacol. 2011. PMID: 20970440 Review.
Cited by
-
Robust hierarchical co-clustering for exploring toxicogenomic biomarkers and their chemical regulators.Sci Rep. 2025 May 14;15(1):16676. doi: 10.1038/s41598-025-99568-7. Sci Rep. 2025. PMID: 40369321 Free PMC article.
-
Impact of climate change on Boro rice production in Bangladesh: Evidence from time series modeling.PLoS One. 2025 Jul 23;20(7):e0328699. doi: 10.1371/journal.pone.0328699. eCollection 2025. PLoS One. 2025. PMID: 40700376 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical